Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Elara MD vs T2D.com

Elara MD
Graded #466

Higher grade

vs+0.5
T2D.com
Graded #474

Lower grade

The verdict

Elara MD takes it — 53.5/100 to 53/100, but only just.

Elara MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Elara MD is a weight-loss and wellness telehealth platform offering weekly injectable GLP-1 therapy alongside a peptide menu (NAD+, sermorelin, glutathione). T2D.com is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueElara MD +11
40
29
Dose & formulationT2D.com +10
54
64
Clinical oversightT2D.com +6
63
69
Labs & monitoringEven
52
52
FulfillmentElara MD +8
66
58
Contract termsEven
55
55
Elara MD · left barT2D.com · right bar

The numbers

MetricElara MDT2D.com
WeighScore53.5/10053/100
GradeCC
Scorecard rank#466#474
Semaglutide$249/mo (0.2 mg dose, compounded)$999/mo (starting dose, compounded)
Tirzepatide$349/mo (2.0 mg dose, compounded)$999/mo (starting dose, compounded)
CoverageCoverage not published1 state
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Elara MD

Graded #466 · C

Strengths

  • Dose-banded monthly pricing published on-site ($249–$649/mo across tiers)
  • Both a semaglutide-range and a tirzepatide-range (GLP-1/GIP) option, plus microdosing
  • Medication included in the monthly price with free fast shipping when prescribed
  • Broad reach claimed (over 40 states)

Where it loses points

  • Molecules not named on-site (only 'Personalized GLP-1') — compounded status is inferred
  • No FDA compounded-medication disclaimer published
  • No named compounding pharmacy partner — prescriptions are patient-directed
  • LegitScript certification, medical director, and full state list not disclosed
  • Pricier than several compounded competitors
T2D.com

Graded #474 · C

Strengths

  • Built specifically for type 2 diabetic and pre-diabetic patients
  • Integrated service — prescriber, pharmacy, and delivery handled in one flow
  • Offers both compounded semaglutide and compounded tirzepatide
  • Temperature-controlled home delivery via UPS or FedEx
  • Ongoing prescriber monitoring and support included

Where it loses points

  • No pricing published on the public website — must register to see costs
  • No states list published on the site
  • Newer brand with limited independent reviews
  • Compounded only — no brand-name Ozempic, Wegovy, or Mounjaro

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard